Makes clinical trials in Asia faster and cheaper

The Singapore clinical trials market is expected to grow to over US$166 million by 2015 – with more than 80% of trials being of international origin. Yet, to date, there has not been a locally-based, accredited provider of bio-analytical services to support the country's growing clinical trials and R&D markets. Read More...